Loading…

Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy

The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is unknown among Chinese patients with MN. Here, we measured anti-PLA2R antibody in the serum of 60 patients with idiopathic MN, 20...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2011-06, Vol.22 (6), p.1137-1143
Main Authors: WEISONG QIN, BECK, Laurence H, CAIHONG ZENG, ZHAOHONG CHEN, SHIJUN LI, KE ZUO, SALANT, David J, ZHIHONG LIU
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c530t-41756c83c412702e694de0e18183d46c835cf8c80bc708cd8af37611bb55ab753
cites cdi_FETCH-LOGICAL-c530t-41756c83c412702e694de0e18183d46c835cf8c80bc708cd8af37611bb55ab753
container_end_page 1143
container_issue 6
container_start_page 1137
container_title Journal of the American Society of Nephrology
container_volume 22
creator WEISONG QIN
BECK, Laurence H
CAIHONG ZENG
ZHAOHONG CHEN
SHIJUN LI
KE ZUO
SALANT, David J
ZHIHONG LIU
description The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is unknown among Chinese patients with MN. Here, we measured anti-PLA2R antibody in the serum of 60 patients with idiopathic MN, 20 with lupus-associated MN, 16 with hepatitis B (HBV)-associated MN, and 10 with tumor-associated MN. Among patients with idiopathic MN, 49 (82%) had detectable anti-PLA2R autoantibodies using a Western blot assay; an assay with greater sensitivity detected very low titers of anti-PLA2R in 10 of the remaining 11 patients. Using the standard assay, we detected anti-PLA2R antibody in only 1 patient with lupus, 1 with HBV, and 3 with cancer, producing an overall specificity of 89% in this cohort limited to patients with secondary MN. The enhanced assay detected low titers of anti-PLA2R in only 2 additional samples of HBV-associated MN. In summary, these results suggest that PLA2R is a major target antigen in Chinese idiopathic MN and that detection of anti-PLA2R is a sensitive test for idiopathic MN.
doi_str_mv 10.1681/asn.2010090967
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3103733</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>869791770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-41756c83c412702e694de0e18183d46c835cf8c80bc708cd8af37611bb55ab753</originalsourceid><addsrcrecordid>eNpVkElLxEAQhRtR3K8eJRfxlLEqnV5yEYK4gY7icm46nY6JZNKxOyPMvzfDjNupCt5Xr6oeIUcIE-QSz3ToJgkgQAYZFxtkFxmlMU0ZbI49pDzmXNAdshfCOwCyRIhtspMg4xwY2yV53g1N_Fi70NeubXodbJQn0ZM1th-cj5Zy4cpF1HTRvZ0VXnduHqKp7Wvvej3UiwOyVek22MN13SevV5cvFzfx3cP17UV-FxtGYYhTFIwbSU2KiYDE8iwtLViUKGmZLhVmKmkkFEaANKXUFRUcsSgY04VgdJ-cr3z7eTGzpbHd4HWret_MtF8opxv1X-maWr25T0URqKB0NDhdG3j3MbdhULMmGNu2urPjT0ryTGQoBIzkZEUa70LwtvrZgqCWsav8eap-Yx8Hjv_e9oN_5zwCJ2tAB6PbaozRNOGXSxNMGE3pF7aTiqM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>869791770</pqid></control><display><type>article</type><title>Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy</title><source>PubMed Central (Open access)</source><source>Elektronische Zeitschriftenbibliothek (Open access)</source><creator>WEISONG QIN ; BECK, Laurence H ; CAIHONG ZENG ; ZHAOHONG CHEN ; SHIJUN LI ; KE ZUO ; SALANT, David J ; ZHIHONG LIU</creator><creatorcontrib>WEISONG QIN ; BECK, Laurence H ; CAIHONG ZENG ; ZHAOHONG CHEN ; SHIJUN LI ; KE ZUO ; SALANT, David J ; ZHIHONG LIU</creatorcontrib><description>The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is unknown among Chinese patients with MN. Here, we measured anti-PLA2R antibody in the serum of 60 patients with idiopathic MN, 20 with lupus-associated MN, 16 with hepatitis B (HBV)-associated MN, and 10 with tumor-associated MN. Among patients with idiopathic MN, 49 (82%) had detectable anti-PLA2R autoantibodies using a Western blot assay; an assay with greater sensitivity detected very low titers of anti-PLA2R in 10 of the remaining 11 patients. Using the standard assay, we detected anti-PLA2R antibody in only 1 patient with lupus, 1 with HBV, and 3 with cancer, producing an overall specificity of 89% in this cohort limited to patients with secondary MN. The enhanced assay detected low titers of anti-PLA2R in only 2 additional samples of HBV-associated MN. In summary, these results suggest that PLA2R is a major target antigen in Chinese idiopathic MN and that detection of anti-PLA2R is a sensitive test for idiopathic MN.</description><identifier>ISSN: 1046-6673</identifier><identifier>EISSN: 1533-3450</identifier><identifier>DOI: 10.1681/asn.2010090967</identifier><identifier>PMID: 21566055</identifier><identifier>CODEN: JASNEU</identifier><language>eng</language><publisher>Washington, DC: American Society of Nephrology</publisher><subject>Adult ; Aged ; Antibodies, Anti-Idiotypic - blood ; Biological and medical sciences ; Biomarkers - blood ; Blotting, Western ; Case-Control Studies ; China ; Clinical Research ; Female ; Glomerulonephritis ; Glomerulonephritis, Membranous - diagnosis ; Glomerulonephritis, Membranous - ethnology ; Glomerulonephritis, Membranous - immunology ; Humans ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Receptors, Phospholipase A2 - immunology ; Sensitivity and Specificity</subject><ispartof>Journal of the American Society of Nephrology, 2011-06, Vol.22 (6), p.1137-1143</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 by the American Society of Nephrology 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-41756c83c412702e694de0e18183d46c835cf8c80bc708cd8af37611bb55ab753</citedby><cites>FETCH-LOGICAL-c530t-41756c83c412702e694de0e18183d46c835cf8c80bc708cd8af37611bb55ab753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103733/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103733/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24212534$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21566055$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WEISONG QIN</creatorcontrib><creatorcontrib>BECK, Laurence H</creatorcontrib><creatorcontrib>CAIHONG ZENG</creatorcontrib><creatorcontrib>ZHAOHONG CHEN</creatorcontrib><creatorcontrib>SHIJUN LI</creatorcontrib><creatorcontrib>KE ZUO</creatorcontrib><creatorcontrib>SALANT, David J</creatorcontrib><creatorcontrib>ZHIHONG LIU</creatorcontrib><title>Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy</title><title>Journal of the American Society of Nephrology</title><addtitle>J Am Soc Nephrol</addtitle><description>The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is unknown among Chinese patients with MN. Here, we measured anti-PLA2R antibody in the serum of 60 patients with idiopathic MN, 20 with lupus-associated MN, 16 with hepatitis B (HBV)-associated MN, and 10 with tumor-associated MN. Among patients with idiopathic MN, 49 (82%) had detectable anti-PLA2R autoantibodies using a Western blot assay; an assay with greater sensitivity detected very low titers of anti-PLA2R in 10 of the remaining 11 patients. Using the standard assay, we detected anti-PLA2R antibody in only 1 patient with lupus, 1 with HBV, and 3 with cancer, producing an overall specificity of 89% in this cohort limited to patients with secondary MN. The enhanced assay detected low titers of anti-PLA2R in only 2 additional samples of HBV-associated MN. In summary, these results suggest that PLA2R is a major target antigen in Chinese idiopathic MN and that detection of anti-PLA2R is a sensitive test for idiopathic MN.</description><subject>Adult</subject><subject>Aged</subject><subject>Antibodies, Anti-Idiotypic - blood</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blotting, Western</subject><subject>Case-Control Studies</subject><subject>China</subject><subject>Clinical Research</subject><subject>Female</subject><subject>Glomerulonephritis</subject><subject>Glomerulonephritis, Membranous - diagnosis</subject><subject>Glomerulonephritis, Membranous - ethnology</subject><subject>Glomerulonephritis, Membranous - immunology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Receptors, Phospholipase A2 - immunology</subject><subject>Sensitivity and Specificity</subject><issn>1046-6673</issn><issn>1533-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNpVkElLxEAQhRtR3K8eJRfxlLEqnV5yEYK4gY7icm46nY6JZNKxOyPMvzfDjNupCt5Xr6oeIUcIE-QSz3ToJgkgQAYZFxtkFxmlMU0ZbI49pDzmXNAdshfCOwCyRIhtspMg4xwY2yV53g1N_Fi70NeubXodbJQn0ZM1th-cj5Zy4cpF1HTRvZ0VXnduHqKp7Wvvej3UiwOyVek22MN13SevV5cvFzfx3cP17UV-FxtGYYhTFIwbSU2KiYDE8iwtLViUKGmZLhVmKmkkFEaANKXUFRUcsSgY04VgdJ-cr3z7eTGzpbHd4HWret_MtF8opxv1X-maWr25T0URqKB0NDhdG3j3MbdhULMmGNu2urPjT0ryTGQoBIzkZEUa70LwtvrZgqCWsav8eap-Yx8Hjv_e9oN_5zwCJ2tAB6PbaozRNOGXSxNMGE3pF7aTiqM</recordid><startdate>20110601</startdate><enddate>20110601</enddate><creator>WEISONG QIN</creator><creator>BECK, Laurence H</creator><creator>CAIHONG ZENG</creator><creator>ZHAOHONG CHEN</creator><creator>SHIJUN LI</creator><creator>KE ZUO</creator><creator>SALANT, David J</creator><creator>ZHIHONG LIU</creator><general>American Society of Nephrology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110601</creationdate><title>Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy</title><author>WEISONG QIN ; BECK, Laurence H ; CAIHONG ZENG ; ZHAOHONG CHEN ; SHIJUN LI ; KE ZUO ; SALANT, David J ; ZHIHONG LIU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-41756c83c412702e694de0e18183d46c835cf8c80bc708cd8af37611bb55ab753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies, Anti-Idiotypic - blood</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blotting, Western</topic><topic>Case-Control Studies</topic><topic>China</topic><topic>Clinical Research</topic><topic>Female</topic><topic>Glomerulonephritis</topic><topic>Glomerulonephritis, Membranous - diagnosis</topic><topic>Glomerulonephritis, Membranous - ethnology</topic><topic>Glomerulonephritis, Membranous - immunology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Receptors, Phospholipase A2 - immunology</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WEISONG QIN</creatorcontrib><creatorcontrib>BECK, Laurence H</creatorcontrib><creatorcontrib>CAIHONG ZENG</creatorcontrib><creatorcontrib>ZHAOHONG CHEN</creatorcontrib><creatorcontrib>SHIJUN LI</creatorcontrib><creatorcontrib>KE ZUO</creatorcontrib><creatorcontrib>SALANT, David J</creatorcontrib><creatorcontrib>ZHIHONG LIU</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WEISONG QIN</au><au>BECK, Laurence H</au><au>CAIHONG ZENG</au><au>ZHAOHONG CHEN</au><au>SHIJUN LI</au><au>KE ZUO</au><au>SALANT, David J</au><au>ZHIHONG LIU</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><addtitle>J Am Soc Nephrol</addtitle><date>2011-06-01</date><risdate>2011</risdate><volume>22</volume><issue>6</issue><spage>1137</spage><epage>1143</epage><pages>1137-1143</pages><issn>1046-6673</issn><eissn>1533-3450</eissn><coden>JASNEU</coden><abstract>The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is unknown among Chinese patients with MN. Here, we measured anti-PLA2R antibody in the serum of 60 patients with idiopathic MN, 20 with lupus-associated MN, 16 with hepatitis B (HBV)-associated MN, and 10 with tumor-associated MN. Among patients with idiopathic MN, 49 (82%) had detectable anti-PLA2R autoantibodies using a Western blot assay; an assay with greater sensitivity detected very low titers of anti-PLA2R in 10 of the remaining 11 patients. Using the standard assay, we detected anti-PLA2R antibody in only 1 patient with lupus, 1 with HBV, and 3 with cancer, producing an overall specificity of 89% in this cohort limited to patients with secondary MN. The enhanced assay detected low titers of anti-PLA2R in only 2 additional samples of HBV-associated MN. In summary, these results suggest that PLA2R is a major target antigen in Chinese idiopathic MN and that detection of anti-PLA2R is a sensitive test for idiopathic MN.</abstract><cop>Washington, DC</cop><pub>American Society of Nephrology</pub><pmid>21566055</pmid><doi>10.1681/asn.2010090967</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1046-6673
ispartof Journal of the American Society of Nephrology, 2011-06, Vol.22 (6), p.1137-1143
issn 1046-6673
1533-3450
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3103733
source PubMed Central (Open access); Elektronische Zeitschriftenbibliothek (Open access)
subjects Adult
Aged
Antibodies, Anti-Idiotypic - blood
Biological and medical sciences
Biomarkers - blood
Blotting, Western
Case-Control Studies
China
Clinical Research
Female
Glomerulonephritis
Glomerulonephritis, Membranous - diagnosis
Glomerulonephritis, Membranous - ethnology
Glomerulonephritis, Membranous - immunology
Humans
Male
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Receptors, Phospholipase A2 - immunology
Sensitivity and Specificity
title Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A13%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Phospholipase%20A2%20Receptor%20Antibody%20in%20Membranous%20Nephropathy&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=WEISONG%20QIN&rft.date=2011-06-01&rft.volume=22&rft.issue=6&rft.spage=1137&rft.epage=1143&rft.pages=1137-1143&rft.issn=1046-6673&rft.eissn=1533-3450&rft.coden=JASNEU&rft_id=info:doi/10.1681/asn.2010090967&rft_dat=%3Cproquest_pubme%3E869791770%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c530t-41756c83c412702e694de0e18183d46c835cf8c80bc708cd8af37611bb55ab753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=869791770&rft_id=info:pmid/21566055&rfr_iscdi=true